MoonLake Immunotherapeutics price target raised to $81 from $71 at BTIG
BTIG raised the firm’s price target on MoonLake Immunotherapeutics (MLTX) to $81 from $71 and keeps a Buy rating on the shares. The firm ...
BrightSpring Health Services, Inc. (NASDAQ:BTSG) Given Consensus Rating of “Moderate Buy” by Brokerages
BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) has earned a consensus recommendation of “Moderate Buy” ...
5 medtech trends to watch in 2025
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...
bovnews12h
Ready Capital Corp (RC) Posted -12.24% Profit Margin Last Year—Can It Hold Up?
On Wednesday, Ready Capital Corp (RC) stock saw a decline, ending the day at $6.66 which represents a decrease of $-0.20 or -2.92% from the prior close of $6.86. The stock opened at $6.82 and touched ...
bovnews14h
Why Did Capital One Financial Corp (COF) Plummet? Key Factors Explained
Capital One Financial Corp (COF) stock saw a decline, ending the day at $180.14 which represents a decrease of $-1.75 or -0.96% from the prior close of $181.89. The stock opened at $180.45 and touched ...
Energy stocks take 'early lead' in 2025 as natural gas shines
“In 2025, the energy sector will be less about barrels of oil and more about ... billions of cubic feet of natural gas demand in 2025 and beyond as the technology sector intersects with the energy ...
MicroStrategy Stock Is as Hot as Bitcoin. These Are the Risks.
The consensus price target for MicroStrategy is just under $550 a share, 70% above its current level. The warning signs are ...